David W. Nassif - Net Worth and Insider Trading
David W. Nassif Net Worth
The estimated net worth of David W. Nassif is at least $0 dollars as of 2024-05-08. David W. Nassif is the EVP and CFO of SteadyMed Ltd and owns about 0 shares of SteadyMed Ltd (STDY) stock worth over $0. Details can be seen in David W. Nassif's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David W. Nassif has not made any transactions after 2018-08-30 and currently still holds the listed stock(s).
Transaction Summary of David W. Nassif
David W. Nassif Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David W. Nassif owns 2 companies in total, including Sio Gene Therapies Inc (SIOX) , and SteadyMed Ltd (STDY) .
Click here to see the complete history of David W. Nassif’s form 4 insider trades.
Insider Ownership Summary of David W. Nassif
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SIOX | Sio Gene Therapies Inc | 2019-07-01 | Principal Financial Officer |
| STDY | SteadyMed Ltd | 2018-08-30 | EVP and CFO |
David W. Nassif Latest Holdings Summary
David W. Nassif currently owns a total of 1 stock. David W. Nassif owns 0 shares of SteadyMed Ltd (STDY) as of August 30, 2018, with a value of $0.
Latest Holdings of David W. Nassif
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STDY | SteadyMed Ltd | 2018-08-30 | 0 | 4.73 | 0 |
Holding Weightings of David W. Nassif
David W. Nassif Form 4 Trading Tracker
According to the SEC Form 4 filings, David W. Nassif has made a total of 0 transactions in SteadyMed Ltd (STDY) over the past 5 years. The most-recent trade in SteadyMed Ltd is the sale of 22,157 shares on August 30, 2018, which brought David W. Nassif around $98,820.
Insider Trading History of David W. Nassif
- 1
David W. Nassif Trading Performance
David W. Nassif Ownership Network
David W. Nassif Owned Company Details
What does Sio Gene Therapies Inc do?
Who are the key executives at Sio Gene Therapies Inc?
David W. Nassif is the Principal Financial Officer of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , Chief Executive Officer Pavan Cheruvu , and 10 percent owner Roivant Sciences Ltd. .
Sio Gene Therapies Inc (SIOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sio Gene Therapies Inc Insider Transactions
David W. Nassif Mailing Address
Above is the net worth, insider trading, and ownership report for David W. Nassif. You might contact David W. Nassif via mailing address: C/o Steadymed Therapeutics, Inc., 2410 Camino Ramon, San Ramon Ca 94583.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
